Loading...
Loading...
CDC PLACES (2023, crude) estimates 12.8% of adults in Tulsa have diagnosed diabetes — 0.8 points above the U.S. 12% figure. Census population 413,066. Oklahoma Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Tulsa clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Tulsa storefront.
PRP Injections & Treatment Systems in Tulsa, OK for clinics & physicians. Add PRP injections to your pract… Compliance support & pricing — contact Hawk Medical.
14.4% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. CDC PLACES (2023, crude) estimates 12.8% of adults in Tulsa have diagnosed diabetes — 0.8 points above the U.S. 12% figure. Population 413,066. The useful question is not “do you have a warehouse on our street?” — it is whether receiving, IFUs, and JH documentation are ready before the first application of prp injections.
National PRP Injections & Treatment Systems notes (how the product actually works)14.4% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city of 250k–500k with 413,066 residents will still mix those payers. CDC PLACES (2023, crude) estimates 12.8% of adults in Tulsa have diagnosed diabetes — 0.8 points above the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Tulsa trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 12.8% of adults in Tulsa have diagnosed diabetes — 0.8 points above the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 12.8% of adults — 0.8 points above the U.S. 12% figure. Obesity is 37.5%; arthritis is 25.1%. That is place-level BRFSS modeling, not a clinic census and not a Tulsa trial.
A 510(k)-cleared device has a different regulatory file than a 361 HCT/P. Do not store, bill, or describe them as the same SKU family. Your SOP should split receiving and indication language.
Oklahoma is not in CDC’s core Diabetes Belt list, but 12% national prevalence still means diabetic wounds will appear. Stock from your clinic mix, not from belt branding.
No. PRP (autologous) and cellular/tissue products (allograft/skin substitutes) sit on different coding and coverage paths. Novitas Solutions LCDs for CTPs do not automatically cover PRP injections. Build separate protocols and fee tickets.
Bring specialty, monthly joint / regenerative volume, and whether you bill JH FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 12.8% diabetes and 25.1% arthritis for Tulsa — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Tulsa, OK.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Tulsa is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Tulsa — 0.8 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Oklahoma Part B wound biologics follow this contractor (siblings: AR, CO, LA, MS, NM, TX). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Tulsa. Useful for joint-program math; still needs a diagnosis and privileging.
No Tulsa storefront. Joe Bradley is an active practice owner. prp injections stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.